APrevent Medical Inc. Secures $6 Million in Series D Funding Led by Taiwania Capital
APrevent Medical Inc. is thrilled to announce the successful Series D funding round led by Taiwania Capital, a leading venture capital firm in Taiwan , backed by Taiwan’s public and private sectors which focus on investing in innovative companies in High-tech and Biotech fields.
2024-03-29
APrevent VOIS receives 2024 German NUB subsidy
APrevent VOIS, with its features of post-operative adjustment and standardized surgical procedures, effectively reduces the consumption of medical resources and provides high cost-effectiveness, has won the 2024 German New Medical Technology Additional Payment (NUB) subsidy.
2024-02-06
Loading...